New week, new insights! Join CTML for our weekly seminar series on Wednesday, October 22nd as Romain Neugebauer, Research Scientist at Kaiser Permanente, shares their latest work on "Comparison of GLP-1RA, SGLT2i, and Other Type 2 Diabetes Pharmacotherapy Regimens Using Targeted Learning – Approach and Results from the ON TARGET DM Study." This talk will take place at 12:00PM at Berkeley Way West, 5th Floor, Room 5401.
The PCORI-funded ON TARGET DM study was designed to help patients with type 2 diabetes and their clinicians identify glucose-lowering medication regimens that have the most favorable effects on heart health and other patient-important outcomes. This talk will focus on describing the analytic approach of the study, its motivation, and implementation.